Xiaolin Dong
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
-
- Pharmacology and Obesity Treatment
Papers in
-
- Diabetes Treatment and Management 11
- Diabetes Management and Research 7
- Diabetes, Cardiovascular Risks, and Lipoproteins 2
-
- Metabolism, Diabetes, and Cancer 6
- Co-authors
- Guoyue Yuan (4 shared papers)Yu Sun (1 shared paper)Ming Liu (5 shared papers)Li Chen (1 shared paper)Yang Liu (1 shared paper)Linong Ji (3 shared papers)Yufeng Li (2 shared papers)Soo Lim (2 shared papers)
In The Last Decade
Xiaolin Dong
13 papers receiving 212 citations
Peers
Comparison fields: 5 of 37
- Endocrinology, Diabetes and Metabolism 181
- Pharmacology 38
- Public Health, Environmental and Occupational Health 40
- Molecular Biology 93
- Cardiology and Cardiovascular Medicine 24
Countries citing papers authored by Xiaolin Dong
This map shows the geographic impact of Xiaolin Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Dong more than expected).
Fields of papers citing papers by Xiaolin Dong
This network shows the impact of papers produced by Xiaolin Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Dong. The network helps show where Xiaolin Dong may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaolin Dong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 71 | |
| 2 | 2011 | 50 | |
| 3 | 2019 | 20 | |
| 4 | 2022 | 18 | |
| 5 | 2022 | 17 | |
| 6 | 2021 | 15 | |
| 7 | 2023 | 7 | |
| 8 | 2017 | 7 | |
| 9 | 2023 | 4 | |
| 10 | 2024 | 3 | |
| 11 | 2020 | 2 | |
| 12 | 2023 | 1 | |
| 13 | 2024 | 1 | |
| 14 | 2025 | 0 | |
| 15 | 2025 | 0 |
About Xiaolin Dong
Xiaolin Dong is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Surgery, Pharmacology and Genetics, having authored 15 papers that have together received 216 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (11 papers), Diabetes Management and Research (7 papers), Metabolism, Diabetes, and Cancer (6 papers), Pancreatic function and diabetes (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Colorectal Cancer Treatments and Studies (1 paper), Nutritional Studies and Diet (1 paper) and Cancer, Lipids, and Metabolism (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (181 citations), Pharmacology (38 citations), Public Health, Environmental and Occupational Health (40 citations), Molecular Biology (93 citations) and Cardiology and Cardiovascular Medicine (24 citations). Xiaolin Dong has collaborated with scholars based in China, Germany and France. Frequent co-authors include Guoyue Yuan, Yu Sun, Ming Liu, Li Chen, Yang Liu, Linong Ji, Yufeng Li, Soo Lim, Freddy G. Eliaschewitz and Yiming Li. Their work appears in journals such as Diabetes Obesity and Metabolism, Pharmacological Research, Diabetes, Oncotarget and Frontiers in Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.